140 related articles for article (PubMed ID: 21599811)
1. Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
Cancer Sci; 2011 Sep; 102(9):1724-33. PubMed ID: 21599811
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Shimizu T; Tatsuta T; Sugihara H; Endo Y; Kurumi Y; Tani T
Int J Clin Oncol; 2012 Jun; 17(3):240-9. PubMed ID: 21773689
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
Cancer Sci; 2013 Jul; 104(7):958-64. PubMed ID: 23566254
[TBL] [Abstract][Full Text] [Related]
4. The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development.
Jang TJ; Park JB; Lee JI
Korean J Pathol; 2013 Aug; 47(4):340-7. PubMed ID: 24009629
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
[TBL] [Abstract][Full Text] [Related]
6. The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients' survival.
Gulubova M; Ananiev J; Yovchev Y; Julianov A; Karashmalakov A; Vlaykova T
J Mol Histol; 2013 Dec; 44(6):679-92. PubMed ID: 23801404
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
9. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
Droeser RA; Hirt C; Eppenberger-Castori S; Zlobec I; Viehl CT; Frey DM; Nebiker CA; Rosso R; Zuber M; Amicarella F; Iezzi G; Sconocchia G; Heberer M; Lugli A; Tornillo L; Oertli D; Terracciano L; Spagnoli GC
PLoS One; 2013; 8(5):e64814. PubMed ID: 23734221
[TBL] [Abstract][Full Text] [Related]
10. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
11. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma.
Konishi Y; Kawamata F; Nishihara H; Homma S; Kato Y; Tsuda M; Kohsaka S; Einama T; Liu C; Yoshida T; Nagatsu A; Tanino M; Tanaka S; Kawamura H; Kamiyama T; Taketomi A
Med Oncol; 2018 Jun; 35(7):104. PubMed ID: 29892782
[TBL] [Abstract][Full Text] [Related]
12. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
13. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
14. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
15. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
[TBL] [Abstract][Full Text] [Related]
16. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
17. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.
Raposo TP; Comes MS; Idowu A; Agit B; Hassall J; Fadhil W; Nica R; Ecker R; Yao T; Ilyas M
Exp Mol Pathol; 2018 Jun; 104(3):190-198. PubMed ID: 29653092
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
19. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
[TBL] [Abstract][Full Text] [Related]
20. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
Omran OM
J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
